Institutional investors purchased a net $3.1 million shares of OPK during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 18.56% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS IRE... Bought 3.8 Thousand shares of OPKO Health Inc
CREDIT SUISSE AG Bought 999.00 shares of OPKO Health Inc